These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 21164386)
1. Clinical relevance of shiga toxin concentrations in the blood of patients with hemolytic uremic syndrome. Brigotti M; Tazzari PL; Ravanelli E; Carnicelli D; Rocchi L; Arfilli V; Scavia G; Minelli F; Ricci F; Pagliaro P; Ferretti AV; Pecoraro C; Paglialonga F; Edefonti A; Procaccino MA; Tozzi AE; Caprioli A Pediatr Infect Dis J; 2011 Jun; 30(6):486-90. PubMed ID: 21164386 [TBL] [Abstract][Full Text] [Related]
2. Flow cytometry detection of Shiga toxins in the blood from children with hemolytic uremic syndrome. Tazzari PL; Ricci F; Carnicelli D; Caprioli A; Tozzi AE; Rizzoni G; Conte R; Brigotti M Cytometry B Clin Cytom; 2004 Sep; 61(1):40-4. PubMed ID: 15351981 [TBL] [Abstract][Full Text] [Related]
3. [Hemolytic uremic syndrome in children of Mendoza, Argentina: association with Shiga toxin-producing Escherichia coli infection]. Rivas M; Balbi L; Miliwebsky ES; García B; Tous MI; Leardini NA; Prieto MA; Chillemi GM; de Principi ME Medicina (B Aires); 1998; 58(1):1-7. PubMed ID: 9674201 [TBL] [Abstract][Full Text] [Related]
5. New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome. Karch H; Friedrich AW; Gerber A; Zimmerhackl LB; Schmidt MA; Bielaszewska M Semin Thromb Hemost; 2006 Mar; 32(2):105-12. PubMed ID: 16575685 [TBL] [Abstract][Full Text] [Related]
6. Association between hemolytic uremic syndrome and verotoxin-producing strains of E. coli. Jure MA; de Saab OA; de Castillo MC; Sesma F; Miceli S; Zamora AM; de Ruiz Holgado AP; de Nader OM Rev Latinoam Microbiol; 1998; 40(1-2):1-8. PubMed ID: 10932728 [TBL] [Abstract][Full Text] [Related]
10. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006. Espié E; Grimont F; Mariani-Kurkdjian P; Bouvet P; Haeghebaert S; Filliol I; Loirat C; Decludt B; Minh NN; Vaillant V; de Valk H Pediatr Infect Dis J; 2008 Jul; 27(7):595-601. PubMed ID: 18520972 [TBL] [Abstract][Full Text] [Related]
11. Particulate Shiga Toxin 2 in Blood is Associated to the Development of Hemolytic Uremic Syndrome in Children. Brigotti M; He X; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Tazzari PL; Ricci F; Patfield SA; Testa S; Paglialonga F; Picicco D; Caprioli A; Scavia G; Morabito S; Ardissino G Thromb Haemost; 2020 Jan; 120(1):107-120. PubMed ID: 31858520 [TBL] [Abstract][Full Text] [Related]
12. Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome. Arvidsson I; Ståhl AL; Hedström MM; Kristoffersson AC; Rylander C; Westman JS; Storry JR; Olsson ML; Karpman D J Immunol; 2015 Mar; 194(5):2309-18. PubMed ID: 25637016 [TBL] [Abstract][Full Text] [Related]
13. Microparticle generation and leucocyte death in Shiga toxin-mediated HUS. Ge S; Hertel B; Emden SH; Beneke J; Menne J; Haller H; von Vietinghoff S Nephrol Dial Transplant; 2012 Jul; 27(7):2768-75. PubMed ID: 22234918 [TBL] [Abstract][Full Text] [Related]
14. Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS). Exeni RA; Fernandez-Brando RJ; Santiago AP; Fiorentino GA; Exeni AM; Ramos MV; Palermo MS Pediatr Nephrol; 2018 Nov; 33(11):2057-2071. PubMed ID: 29372302 [TBL] [Abstract][Full Text] [Related]
16. [Therapy for children with Shiga toxin-E. coli-associated hemolytic uremic syndrome]. Ito K; Hattori M; Matsumoto N Nihon Rinsho; 2002 Jun; 60(6):1126-30. PubMed ID: 12078084 [TBL] [Abstract][Full Text] [Related]
17. Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytes. Geelen JM; van der Velden TJ; Te Loo DM; Boerman OC; van den Heuvel LP; Monnens LA Nephrol Dial Transplant; 2007 Mar; 22(3):749-55. PubMed ID: 17127697 [TBL] [Abstract][Full Text] [Related]
19. "Children on the frontline against E. coli": typical hemolytic-uremic syndrome. Andersen H Clin Lab Sci; 2005; 18(2):90-9. PubMed ID: 15916241 [TBL] [Abstract][Full Text] [Related]
20. Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11. Misselwitz J; Karch H; Bielazewska M; John U; Ringelmann F; Rönnefarth G; Patzer L Pediatr Infect Dis J; 2003 Apr; 22(4):349-54. PubMed ID: 12690276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]